Aggressive traders could probe the long side of STZ at current levels and on a shallow dip.
The main reason most cannabis-related concerns head north to list their shares is banking.
What matters here is the ability to innovate, market, and sell.
Both Aphria and Green Growth's stock prices have sold off since the announcement.
Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
The buy-in from other companies into the space has been far larger.
Tilray's technical history is limited, but a bullish divergence in a key chart could be foreshadowing a rally ahead.